Skip to main content
SpringerLink
Log in

Pharmacological analysis of the rate-decreasing effects of mu and kappa opioids in pigeons

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

The present study investigated the rate-decreasing effects of several mu (morphine andl-methadone) and kappa (bremazocine, U69,593 and U50,488) opioid agonists in pigeons. Mu and kappa agonists were examined alone, in combination with naltrexone or the mu-selective opioid antagonist, β-funaltrexamine (β-FNA), and in pigeons treated chronically with U50,488. Naltrexone was equipotent in shifting the morphine,l-methadone and bremazocine dose-effect curves to the right, but was less potent in shifting the U69,593 dose-effect curve and did not shift the U50,488 dose-effect curve. β-FNA shifted thel-methadone dose-effect curve to the right but did not shift the bremazocine, U69,593 or U50,488 dose-effect curves. Pigeons that developed tolerance to U50,488 following daily administration were cross-tolerant to bremazocine but not tol-methadone. Taken together, these experiments indicate that the rate-decreasing effects of morphine andl-methadone are mediated by mu opioid receptors, whereas the rate-decreasing effects of bremazocine, U69,593 and U50,488 in pigeons differ depending on the pharmacological procedures used to assess their effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

U50,488:

(trans (±) 3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]-benzeneacetamide)

U69,593:

{(5a,7a,8b)-(+)-N-methyl-N-(7-(1-pyrrolidinyl)-l-oxa spiro-(4,5) dec-8-yl) benzeneacetamide}

β-FNA:

beta-funaltrexamine

References

  • Bronson ME, Lin Y-P, Burchett K, Picker MJ, Dykstra LA (1993) Serotonin involvement in the discriminative stimulus effects of κ opioids in pigeons. Psychopharmacology 111:69–77

    Google Scholar 

  • Craft RM, Dykstra LA (1990) Differential cross-tolerance to opioids in squirrel monkeys responding under a shock titration schedule. J Pharmacol Exp Ther 252:945–952

    PubMed  Google Scholar 

  • Craft RM, Picker MJ, Dykstra LA (1989) Differential cross-tolerance to opioid agonists in morphine-tolerant pigeons responding under a schedule of food presentation. J Pharmacol Exp Ther 249:386–393

    PubMed  Google Scholar 

  • Dykstra LA (1990) Butorphanol, levallorphan, nalbuphine and nalorphine as antagonists in the squirrel monkey. J Pharmacol Exp Ther 254:245–252

    PubMed  Google Scholar 

  • Dykstra LA, Gmerek DE, Winger G, Woods JH (1987a) Kappa opioids in rhesus monkeys. I. Diuresis, sedation, analgesia and discriminative stimulus effects. J Pharmacol Exp Ther 242:413–420

    PubMed  Google Scholar 

  • Dykstra LA, Gmerek DE, Winger G, Woods JH (1987b) Kappa opioids in rhesus monkeys. II. Analysis of the antagonistic actions of quadazocine and β-funaltrexamine. J Pharmacol Exp Ther 242:421–427

    PubMed  Google Scholar 

  • France CP, Woods JH (1985) Antagonistic and rate-suppressing effects of opioid antagonists in the pigeon. J Pharmacol Exp Ther 236:442–447

    Google Scholar 

  • France CP, Woods JH (1987) β-Funaltrexamine antagonizes the discriminative stimulus effects of morphine but not naltrexone in pigeons. Psychopharmacology 91:213–216

    Google Scholar 

  • Gmerek DE, Dykstra LA, Woods JH (1987)Kappa opioids in rhesus monkeys. III. Dependence associated with chronic administration. J Pharmacol Exp Ther 242:428–436

    PubMed  Google Scholar 

  • Hayes AG, Sheehan MJ, Tyers MB (1985) Determination of the receptor selectivity of opioid agonists in the guinea-pig ileum and mouse vas deferens by use of β-funaltrexamine. Br J Pharmacol 86:899–904

    PubMed  Google Scholar 

  • Hayes AG, Skingle M, Tyers MB (1986) Reversal by β-funaltrexamine of the antinociceptive effect of opioid agonists in the rat. Br J Pharmacol 88:867–872

    PubMed  Google Scholar 

  • Hayes AG, Birch PP, Cavicchini E (1988) Evidence that the kappa agonist U50,488H has non-opioid actions. J Pharm Pharmacol 40:718–720

    PubMed  Google Scholar 

  • Herling S, Coale EH Jr, Valentino RJ, Hein DW, Woods JH (1980) Narcotic discrimination in pigeons. J Pharmacol Exp Ther 214:139–146

    PubMed  Google Scholar 

  • Ho BY, Takemori AE (1989) Serotonergic involvement in the anti-nociceptive action of and the development of tolerance to thekappa-opioid receptor agonist, U-50,488H. J Pharmacol Exp Ther 250:508–514

    PubMed  Google Scholar 

  • Ho BY, Takemori AE (1990) Attenuation of the antinociceptive action of the selective k-opioid receptor agonist, U-50,488H by ICS-205-930. Eur J Pharmacol 178:371–373

    PubMed  Google Scholar 

  • Katz JL, Goldberg SR (1986) Effects of ethylketazocine and morphine on schedule-controlled behavior in pigeons and squirrel monkeys. J Pharmacol Exp Ther 239:433–441

    PubMed  Google Scholar 

  • Leander JD (1982) Effects of ketazocine, ethylketazocine and phenazocine on schedule-controlled behavior: antagonism by naloxone. Neuropharmacology 21:923–928

    Article  PubMed  Google Scholar 

  • Leander JD (1983) Akappa opioid effect: increased urination in rats. J Pharmacol Exp Ther 224:89–94

    PubMed  Google Scholar 

  • Lord JAH, Waterford AA, Hughes J, Kosterlitz HW (1977) Endogenous opioid peptides: multiple agonists and receptors. Nature 267:495–499

    Article  PubMed  Google Scholar 

  • Magnan J, Paterson SJ, Tavani A, Kosterlitz HW (1982) The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties. Naunyn-Schmiedeberg's Arch Pharmacol 319:197–205

    Article  Google Scholar 

  • Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ (1988) Anatomy of CNS opioid receptors. Trends Neurosci 11:308–314

    Article  PubMed  Google Scholar 

  • Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE (1976) The effects of morphine-and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197:517–532

    PubMed  Google Scholar 

  • Millan MJ, Czlonkowki A, Lipkowki A, Herz A (1989)Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action. J Pharmacol Exp Ther 251:342–350

    PubMed  Google Scholar 

  • Picker MJ, Dykstra LA (1987) Comparison of the discriminative stimulus properties of U50,488 and morphine in pigeons. J Pharmacol Exp Ther 243:938–945

    PubMed  Google Scholar 

  • Picker MJ, Dykstra LA (1989) Discriminative stimulus effects ofmu andkappa opioids in the pigeon: analysis of the effects of full and partialmu andkappa agonists. J Pharmacol Exp Ther 249:557–566

    PubMed  Google Scholar 

  • Picker MJ, Doty P, Negus SS, Mattox SR, Dykstra LA (1990) Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced bymu andkappa opioid agonists. J Pharmacol Exp Ther 254:13–22

    PubMed  Google Scholar 

  • Picker MJ, Negus SS, Powell KR (1991) Differential cross-tolerance to mu and kappa opioid agonists in morphine-tolerant rats responding under a schedule of food presentation. Psychopharmacology 103:129–135

    Google Scholar 

  • Romer D, Buscher H, Hill RC, Maurer R, Petcher TJ, Welle HBA, Bakel HCCK, Akkerman AM (1980) Bremazocine: a potent, long-acting opiate kappa agonist. Life Sci 27:971–978

    Article  PubMed  Google Scholar 

  • Schmauss C, Yaksh TL (1984) In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association ofmu, delta andkappa receptors with visceral chemical and cutaneous thermal stimuli in the rat. J Pharmacol Exp Ther 228:1–12

    PubMed  Google Scholar 

  • Shearman GT, Herz A (1982) Evidence that the discriminative stimulus properties of fentanyl and ethylketocyclazocine are mediated by an interaction with different opiate receptors. J Pharmacol Exp Ther 221:735–739

    PubMed  Google Scholar 

  • Takemori AE, Larson DL, Portoghese PS (1981) The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexone. Eur J Pharmacol 70:445–451

    Article  PubMed  Google Scholar 

  • VonVoigtlander PF, Lewis RA (1982) U50,488, a selective kappa opioid agonist: comparison to other reputed kappa agonists. Prog Neuropsychopharmacol Biol Psychiatry 6:467–470

    Google Scholar 

  • VonVoigtlander PF, Lahti RA, Ludens JH (1983) U50,488: a selective and structurally novel non-mu (kappa) opioid agonist. J Pharmacol Exp Ther 224:7–12

    PubMed  Google Scholar 

  • VonVoigtlander PF, Lewis RA, Neff GL (1984)Kappa opioid analgesia is dependent on serotonergic mechanisms. J Pharmacol Exp Ther 231:270–274

    PubMed  Google Scholar 

  • Wessinger WD, McMillan DE (1986) Quantitative analysis of naloxone antagonism of the discriminative stimulus properties of morphine in the pigeon. Pharmacol Biochem Behav 25:209–214

    Google Scholar 

  • Young AM, Woods JH (1982) Limitations on the antagonistic actions of opioid antagonists. Fed Proc 41:2333–2338

    PubMed  Google Scholar 

  • Zimmerman DM, Leander JD (1990) Selective opioid receptor agonists and antagonists: research tools and potential therapeutic agents. J Med Chem 33:895–902

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychology, University of North Carolina at Chapel Hill, 27599-3270, Chapel Hill, NC, USA

    Adande J. Mattox, Mitchell J. Picker & Linda A. Dykstra

Authors
  1. Adande J. Mattox
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mitchell J. Picker
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Linda A. Dykstra
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This work was supported by US Public Health Service Grant DA 02749 from the National Institute on Drug Abuse. L.A.D. is the recipient of Research Scientist Award DA 00033 and AJM of a Research Supplement for Minority Graduate Research Assistants. Portions of this research were submitted by the first author in partial fulfilment of the requirements for the degree of Doctor of Philosophy

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mattox, A.J., Picker, M.J. & Dykstra, L.A. Pharmacological analysis of the rate-decreasing effects of mu and kappa opioids in pigeons. Psychopharmacology 113, 457–462 (1994). https://doi.org/10.1007/BF02245223

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02245223

Key words

Search

Navigation